Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Advances in drug treatment

to
Auditorium II
Oral presentation session

Innovative health approaches

to
Auditorium III
Oral presentation session

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Gambling: work-related, financial, and criminological issues

to
Room 5B
Oral presentation session

Gambling: work-related, financial, and criminological issues

to
Room 5B
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Support for recovery

to
Room 1.07
Short communication session

Support for recovery

to
Room 1.07
Short communication session
Closed session

ECR Programme — Scientific writing

to
Room 1.10
Workshop

Evaluation of drug consumption rooms: guidance step by step

to
Room 1.15
Workshop

14:20

Enhancing access to harm reduction services in community and prisons: experiences of translating policy into practice and scaling interventions

to
Auditorium I
Major session

Neuroscience and cognition

to
Auditorium III
Short communication session

Neuroscience and cognition

to
Auditorium III
Short communication session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Tobacco, mental health and other substance use

to
Auditorium VII
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Substance use interventions in youth

to
Room 5A
Oral presentation session

Neurocognitive processes in behavioural addictions

to
Room 5B
Oral presentation session

Meetings the needs of women who use drugs or alcohol

to
Room 1.06
Short communication session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

Methods and measurement

to
Room 1.08
Short communication session

Methods and measurement

to
Room 1.08
Short communication session

16:00

Challenges in community-based prevention

to
Auditorium I
Major session

Challenges in community-based prevention

to
Auditorium I
Major session

The recovery journey

to
Auditorium III
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Assessment of behavioural addictions

to
Room 5B
Oral presentation session

Inequalities and needs of migrant groups

to
Room 5C
Oral presentation session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

17:50

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Understanding interrelationships: mental health and substance use

to
Auditorium VII
Oral presentation session

Understanding interrelationships: mental health and substance use

to
Auditorium VII
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

19:30

Why are we not doing better at reducing drug-related deaths?

to
Auditorium I
Big debate

Thu 24 Oct

10:00

Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.

to
Room 1.10
Workshop

Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.

to
Room 1.10
Workshop

Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience

to
Room 1.15
Workshop

11:50

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

Challenges, threats, and opportunities in addiction publishing today

to
Room 1.05
Oral presentation session

Challenges, threats, and opportunities in addiction publishing today

to
Room 1.05
Oral presentation session

Natural language processing for addiction research: a practical primer

to
Room 1.06
Workshop

EU research funding opportunities

to
Room 1.07
Workshop

Contemporary issues

to
Room 1.08
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

14:20

Novel neurobiology - cannabis, cognition and craving

to
Auditorium III
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Young people, mental health and substance use

to
Auditorium VII
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

European prevention curriculum: increasing the use of evidence-based prevention

to
Room 1.06
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

Scenarios for the future of addictions fields by 2040

to
Room 1.10
Workshop

Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief

to
Room 1.15
Workshop

16:00

Alcohol epidemiology: social inequalities

to
Auditorium II
Oral presentation session

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Cannabis legalisation — models and impacts

to
Auditorium VI
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

Protective and risk factors in drug prevention

to
Room 5A
Oral presentation session

Protective and risk factors in drug prevention

to
Room 5A
Oral presentation session

Policy issues in gambling

to
Room 5B
Oral presentation session

From genes to brains

to
Room 1.06
Short communication session

City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction

to
Room 1.07
Workshop

Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain

to
Room 1.08
Oral presentation session

How to respond to real-time drug alerts in European countries ?

to
Room 1.15
Workshop

17:50

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

Behavioural addictions, prevention and theory

to
Room 1.05
Short communication session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Internet, smartphones and social media use

to
Room 1.07
Short communication session

Internet, smartphones and social media use

to
Room 1.07
Short communication session

Fri 25 Oct

10:00

A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe

to
Room 1.15
Workshop

11:50

The ripple effect: International developments in the opioid market and their potential implications for European public health and security

to
Auditorium I
Major session

Gaming and social media use

to
Auditorium III
Oral presentation session

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Psychedelics 2

to
Auditorium VI
Oral presentation session

Unravelling the nexus: understanding drug-related violence across Europe

to
Auditorium VIII
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Gaming and health

to
Room 1.06
Short communication session

Gaming and health

to
Room 1.06
Short communication session

Support for the addiction workforce

to
Room 1.07
Oral presentation session

Support for the addiction workforce

to
Room 1.07
Oral presentation session

How can cannabis policy goals inform the development of evaluation indicators?

to
Room 1.08
Workshop

14:20

Alcohol and other drug policies in the work setting – a perspective on European developments

to
Auditorium II
Oral presentation session

Overdose prevention

to
Auditorium IV
Oral presentation session

Overdose prevention

to
Auditorium IV
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Regulating cannabis supply policies in Europe: navigating the long road to change

to
Auditorium VIII
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Impact of drug policy on drug production & markets

to
Room 5B
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session

Future of opioid markets in Europe: Foresight approaches

to
Room 1.10
Workshop